MARY VOIGHT: Open Payments
NPI 1891072542 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 18 payments from 12 companies in 2025. Trend: 2023 $1,432 · 2024 $1,668 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| ABBVIE INC. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| TOLMAR, INC. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Amgen Inc. | 1 | $17 |
Products named: SHINGRIX, LEQVIO, UBRELVY, Wegovy, Ozempic, JARDIANCE, NEXLETOL, The Cologuard Plus Collection Kit.
Industry payments across SC — which companies pay providers there.
